Differential effect of intestinal neuropeptides on invasion and migration of colon carcinoma cells in vitro

Cancer Lett. 1997 Jun 3;116(1):111-6. doi: 10.1016/s0304-3835(97)00167-5.

Abstract

We investigated the effect of neuropeptides, which are vasoactive intestinal polypeptide (VIP), substance P, (SP), neuropeptide Y (NPY), neurokinin A (NKA), somatostatin (SOM), calcitonin gene-related peptide (CGRP), and leucine-enkephalin (L-ENK), on the invasion of murine Colon 26-L5 adenocarcinoma cells through a reconstituted basement membrane (Matrigel) using a Transwell cell culture chamber assay. VIP, SP, NPY, and L-ENK reduced invasive potential of tumor cells in a concentration-dependent manner, whereas SOM, CGRP, and NKA had no effect. Especially, VIP showed the most effective in inhibiting tumor invasion, and achieved 50% reduction at 10(-6) M. A similar effect by VIP was also observed in cell migration to fibronectin. VIP had no effect on the growth of tumor cells at the concentrations ranging from 10(-10) to 10(-6) M. The suppressed ability of the tumor cell motility by VIP (10(-6) M) was practically recovered by co-treatment with 2',5'-dideoxyadenosine, an adenylate cyclase inhibitor. These results indicate that VIP, among the neuropeptides used, could inhibit Matrigel invasion of Colon 26-L5 carcinoma cells through partial suppression of their motility, and the reduction was associated with an intracellular cAMP-mediated pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / pathology*
  • Animals
  • Biocompatible Materials
  • Calcitonin Gene-Related Peptide / pharmacology
  • Cell Division / drug effects
  • Cell Movement / drug effects
  • Colforsin / pharmacology
  • Collagen / physiology
  • Colonic Neoplasms / pathology*
  • Dideoxyadenosine / analogs & derivatives
  • Dideoxyadenosine / pharmacology
  • Dose-Response Relationship, Drug
  • Drug Combinations
  • Enkephalins / pharmacology
  • Laminin / physiology
  • Leucine / pharmacology
  • Mice
  • Neoplasm Invasiveness / pathology*
  • Neurokinin A / pharmacology
  • Neuropeptide Y / pharmacology
  • Neuropeptides / pharmacology*
  • Proteoglycans / physiology
  • Somatostatin / pharmacology
  • Substance P / pharmacology
  • Tumor Cells, Cultured / drug effects
  • Vasoactive Intestinal Peptide / pharmacology

Substances

  • Biocompatible Materials
  • Drug Combinations
  • Enkephalins
  • Laminin
  • Neuropeptide Y
  • Neuropeptides
  • Proteoglycans
  • matrigel
  • Colforsin
  • Substance P
  • Vasoactive Intestinal Peptide
  • Dideoxyadenosine
  • Somatostatin
  • Neurokinin A
  • Collagen
  • 2',5'-dideoxyadenosine
  • Leucine
  • Calcitonin Gene-Related Peptide